Levesia

Ethinylestradiol and Levonorgestrel, the active ingredients in Levesia, are a combined oral contraceptive presented as an oral tablet for oral use. They are used to prevent pregnancy and to regulate menstrual cycles in women of reproductive age.

GNH USA supplies Levesia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers. Levesia is manufactured under EU GMP guidelines, ensuring consistent potency and safety across batches.

Levesia, a combined oral contraceptive, acts on the hormonal regulation pathway to prevent pregnancy.

- Contraception: prevents unintended pregnancy in women of reproductive age. - Menstrual cycle regulation: helps achieve more regular and predictable menstrual bleeding. - Family planning: provides a reliable method for couples to plan pregnancies.

Levesia may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild stomach upset, often transient. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: temporary swelling or discomfort. - Irregular bleeding: spotting or changes in menstrual flow. - Weight gain: slight increase in body weight.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in veins. - Pulmonary embolism: blockage of lung arteries. - Severe allergic reaction: rash, swelling, or anaphylaxis.

Before prescribing Levesia, healthcare professionals should consider several safety measures. - Smoking status: avoid use in women over 35 who smoke. - Cardiovascular risk: assess history of thromboembolic disorders. - Liver disease: use with caution in hepatic impairment. - Migraine with aura: contraindicated due to increased stroke risk. - Concomitant medications: review for interactions affecting efficacy. - Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

Levesia can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - Certain antiepileptics (e.g., carbamazepine, phenytoin): reduce hormonal levels, decreasing contraceptive efficacy.

Moderate Interactions (Monitor Closely): - Antibiotics (e.g., rifampicin): may lower hormone concentrations. - St. John’s Wort: can diminish contraceptive effect. - Antiretrovirals (e.g., protease inhibitors): may affect hormone metabolism.